While modern pharmacological treatment of epilepsy began as early as 1860 and several broad spectrum drugs were used until 1980, a host of Anti Epileptic Drugs have been developed post 1980 that have targeted actions on epileptogenesis (eg: Na+, Ca++ channels) or act as anticonvulsants. These have fewer side effects as well.
About 30% of cases are pharmacoresistant and need non-pharmacological interventions such as surgery, vagal nerve stimulation, deep brain stimulation, diet, EEG biofeedback, meditation, exercise, enriched environments, gene therapy etc. Each approach has some benefits and side effects and at times be contra-indicated for a specific case.
Overall, a comprehensive seminar that was well appreciated by faculty and students.
- Wolfgang Löscher (2002) Current status and future directions in the pharmacotherapy of epilepsy, TRENDS in Pharmacological Sciences Vol.23 No.3.
- Cameron C. McIntyre et.al. (2004) Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both, Clinical Neurophysiology 115, 1239–1248.
- Alan R. Gaby (2007)Natural Approaches to treat Epilepsy, Alternative Medicine Review Volume 12, No. 1
- Ricardo M. Arida (2009) Physical exercise in epilepsy: What kind of stressor is it? Epilepsy & Behavior 16 381–387.
- Ricardo Mario Arida (2009) Is physical activity beneﬁcial for recovery in temporal lobe epilepsy? Evidences from animal studies, Neuroscience and Biobehavioral Reviews 33, 422–431.
- Meir Bialer et al., (2010) Key factors in the discovery and development of new antiepileptic drugs, Nature Reviews Drug Discovery, volume, 69.
- Michael A. Rogawski (2004) The neurobiology of antiepileptic drugs, NATURE REVIEWS | NEUROSCIENCE volume 5, 553.
- Simon D Shorvon (2005) Handbook of epilepsy treatment, 2nd edition.
- Véronique Riban (2009) Gene therapy in epilepsy, Epilepsia. January ; 50(1): 24–32